Skip to main content
ASHI 50th Annual Meeting Mobile App Main banner
Back

Elizabeth Phillips, MD

Vanderbilt University Medical Center

Dr. Elizabeth Phillips is Professor of Medicine, Dermatology, Pharmacology and Pathology, Microbiology and Immunology at Vanderbilt University Medical Center and Vanderbilt University Medical School. She is the John A. Oates Chair in Clinical Research and Director of Personalized Immunology in the Center for Drug Safety and Immunology. She is a physician scientist clinically trained in Infectious diseases, immunology and clinical pharmacology who has established new clinical and research programs in drug hypersensitivity, pharmacogenomics and personalized immunology across different healthcare systems. She has published over 350 peer reviewed articles and book chapters related to hypersensitivity reactions to drugs and vaccines. She is recognized for elucidating mechanisms and genetic determinants of drug hypersensitivity which have transformed research, clinical practice and training in the United States and Internationally. Amongst her greatest translational accomplishments between 2002-2008 she led the development of the HLA-B*57:01 genetic predictor for abacavir hypersensitivity from its discovery through implementation. Her discovery through translation pipeline continues to pioneer strategies to prevent, diagnose and mitigate harm from true drug hypersensitivity and she is applying novel technologies to understand the single cell pathology of drug hypersensitivity at the site of tissue damage leading to identification of new therapeutic targets. She has also led development of clinical practice and guidance dedicated to the care of drug hypersensitivity patients and her clinics have acted as a model for others within the US and internationally. Her efforts have transformed care across multiple disciplines and she is a true community leader and advocate for those with severe cutaneous adverse drug reactions, working alongside patients and foundations to advance education, awareness and science of drug hypersensitivity.

Disclosure information not submitted.

Presentation(s):